Retrospective cohort analysis of the factor related to the effect of tolvaptan on the medium-and-long term prognosis in patients with hepatic edema - clinical trial of tolvaptan for hepatic edema

IPPON MEDICAL SCHOOL HOSPITA0 个研究点目标入组 400 人开始时间: 2019年5月1日最近更新: 2023年10月17日

试验速览

暂无简介。

•1) The patient who has an applicable heart trouble as follows a) Congestive heart failures more than NYHA class 3 b) The high blood pressure that it is poor in control 2) Dangerously ill patient (except HBV, the HCV) who and has an infectious disease of the activity 3) Patient with a history of the HIV infection 4) Patient during hemodialysis 6) Patient of hepatic encephalopathy having difficulty in appropriate hydration 7) The patient who was treated whom patient 8) who produced the gastrointestinal tract bleeding that a blood transfusion and measures need within four weeks before this study start corresponds below to a) Whole body chemotherapy within four weeks before this study start b) The patient who has difficulty in 9 operation) drug remedy under the general anesthesia within four weeks before this study start 10) When may spoil the security of the patient in 13 patient) others affecting the evaluation of this study entry and result, this study enforcement or when the observance of this study enforcement plan is judged with difficulty by 12 patient) drug abuse that may wake up an allergic reaction for possibility of during a pregnant woman, the nursing and the pregnancy or this patient 11) study drug with the intention

发起方

IPPON MEDICAL SCHOOL HOSPITA